Skip to content
Review Open access

RECENT ADVANCES IN NEUROPATHOLOGY: WHO CNS TUMOR CLASSIFICATION AND MOLECULAR MARKERS

Oct 2026 · International Journal of Drug Delivery Technology · Vol 16 · 0 citations

TL;DR

Current molecular diagnostics technologies, precision medicine and AI in the domain of neuropathology are very useful for making a more accurate diagnosis and treating the patient and give a good basis for future advances in the management of CNS tumors.

Abstract

The role of the neuropathologist in the diagnosis of tumours of the CNS is important and has an impact on the care of the patients. The recent changes made in the 2021 World Health Organization (WHO) Classification of CNS Tumors are highlighted with an emphasis on ‘inclusive’ molecular diagnosis and important molecular markers. Important biomarkers such as IDH, 1p/19q codeletion, EGFR or H3 changes have helped to classify tumors, to view the prognosis and to choose an adequate treatment. Besides, the review emphasizes current molecular diagnostics technologies, precision medicine and AI in the domain of neuropathology. These advances are very useful for making a more accurate diagnosis and treating the patient and give a good basis for future advances in the management of CNS tumors.

Read PDF

Similar papers

Review Open access Oct 2026

Meningioma in the modern era: Updates in stratification and therapeutic approaches

Meningioma is the most common primary intracranial tumor in adults. Most meningiomas have an indolent growth pattern, but some can grow quickly. The World Health Organization (WHO) classification system is the gold standard for tumor grading and relies predominantly on histopathology and limited molecular alterations....

Leeor S. Yefet, Gelareh Zadeh, F. Nassiri · 2 citations
Open access Oct 2026

The Role of Genetic Profiling in Pediatric Brain Tumors

Nine cases with an unresolved referring diagnosis in which DNA methylation profiling, alone or combined with next-generation sequencing (NGS), established the final diagnosis are presented and three illustrative cases are described to highlight the value of an integrated diagnostic approach.

Ivan K. Boronsuzov, K. Minkin, Petia S. Dimova et al. · 0 citations
Review Open access Oct 2026

The 2025 KSPNO Guideline for the Diagnosis and Treatment of Medulloblastoma

Medulloblastoma is the most common malignant pediatric brain tumor. While recent advances in molecular subclassification and therapies have improved clinical outcomes, standardized international treatment guidelines are currently lacking. In this context, the Korean Society for Pediatric Neuro-Oncology (KSPNO) develope...

Nalee Kim, Jaeho Cho, Tae-Young Jung et al. · 0 citations
Review Open access Oct 2026

The 2026 World Health Organization Classification of Tumors of Soft Tissue and Bone

The 6th edition of the World Health Organization Classification of Soft Tissue and Bone Tumors (STB6) integrates the latest scientific and molecular discoveries with decades of pathological expertise to establish a globally accepted common language for diagnosis and clinical behavior. In this volume, the “essential” an...

J. Hornick, J. Bovée, C. Antonescu et al. · 0 citations
Review Open access Nov 2026

Precision Transformation of Meningioma Diagnosis and Treatment: Advances in Molecular Pathology and Systemic Therapy

Meningiomas are the most common primary intracranial tumors of the central nervous system. They exhibit highly heterogeneous biological behavior that current histological grading cannot reliably predict. Currently, there are no standardized systemic treatment regimens for recurrent or refractory meningiomas; therefore,...

Wen-Lin Chen, Yin-Zi Wu, Ru-Xu Geng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.